These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21351549)

  • 21. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
    Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
    Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis.
    Hoseinian Khosroshahi K; Ghaffarifar F; D'Souza S; Sharifi Z; Dalimi A
    Vaccine; 2011 Jan; 29(4):778-83. PubMed ID: 21095254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154.
    Hiszczyńska-Sawicka E; Li H; Xu JB; Holec-Gąsior L; Kur J; Sedcole R; Bickerstaffe R; Stankiewicz M
    Vet Parasitol; 2011 Dec; 183(1-2):72-8. PubMed ID: 21742437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection.
    Zhao HG; Huang FY; Guo JL; Tan GH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Aug; 31(4):284-9. PubMed ID: 24812879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on construction and immune protective effect of recombinant nucleic acid vaccine of Toxoplasma gondii].
    Wei QK
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Apr; 24(2):173-7, 182. PubMed ID: 22799162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice.
    Igarashi M; Kano F; Tamekuni K; Machado RZ; Navarro IT; Vidotto O; Vidotto MC; Garcia JL
    Exp Parasitol; 2008 Mar; 118(3):386-92. PubMed ID: 18154953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of Toxoplasma gondii SRS29C nucleic acid vaccine and comparative immunoprotective study of an SRS29C and SAG1 combination.
    Yan A; Tian J; Ye J; Gao C; Ye L; Zhang D; Song Q
    Mol Biochem Parasitol; 2024 Sep; 259():111630. PubMed ID: 38795969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant.
    Zhou H; Min J; Zhao Q; Gu Q; Cong H; Li Y; He S
    Vaccine; 2012 Feb; 30(10):1800-6. PubMed ID: 22240340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.
    Khosroshahi KH; Ghaffarifar F; Sharifi Z; D'Souza S; Dalimi A; Hassan ZM; Khoshzaban F
    Parasitol Res; 2012 Jul; 111(1):403-11. PubMed ID: 22350714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.
    Guo H; Chen G; Lu F; Chen H; Zheng H
    Chin Med J (Engl); 2001 Mar; 114(3):317-20. PubMed ID: 11780322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Chen H; Chen G; Zheng H; Guo H
    Chin Med J (Engl); 2003 Oct; 116(10):1561-6. PubMed ID: 14570624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological role of surface Toxoplasma gondii antigen in development of vaccine.
    Liu KY; Zhang DB; Wei QK; Li J; Li GP; Yu JZ
    World J Gastroenterol; 2006 Apr; 12(15):2363-8. PubMed ID: 16688826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
    Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
    Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
    Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
    Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].
    Li JH; Wu ST; Weng YB; Gan Y; Liu HB; Liu ML; Zhang RL; Gao ST; Huang DN; Geng YJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):217-21. PubMed ID: 18038782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.
    Sánchez-López EF; Corigliano MG; Albarracín RM; Sander VA; Legarralde A; Bengoa-Luoni SA; Clemente M
    Parasit Vectors; 2019 Mar; 12(1):140. PubMed ID: 30909938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.
    Maraghi S; Ghadiri AA; Tavalla M; Shojaee S; Abdizadeh R
    Biologicals; 2019 Nov; 62():39-49. PubMed ID: 31610951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction of monovalent and compound nucleic acid vaccines against Toxoplasma gondii with gene encoding p30].
    Yang TT; He SY; Jiang H; Gu QM; Cong H; Zhou HY; Zhang JQ; Li Y; Zhao QL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):14-7. PubMed ID: 16042200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
    Liu Q; Gao S; Jiang L; Shang L; Men J; Wang Z; Zhai Y; Xia Z; Hu R; Zhang X; Zhu XQ
    Microbes Infect; 2008 Oct; 10(12-13):1355-62. PubMed ID: 18761418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.